<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002847" GROUP_ID="INFECTN" ID="760100012818402627" MERGED_FROM="" MODIFIED="2008-11-10 12:56:03 +0100" MODIFIED_BY="Reive Robb" REVIEW_NO="SHAH" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2008-11-09 18:13:20 +0000" MODIFIED_BY="[Empty name]">
<TITLE>Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children</TITLE>
<CONTACT>
<PERSON ID="14300" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Seokyung</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hahn</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor of Medical Statistics</POSITION>
<EMAIL_1>hahns@snu.ac.kr</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+82 10 2769 7549</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Medical Research Collaborating Center</DEPARTMENT>
<ORGANISATION>Seoul National University Hospital</ORGANISATION>
<ADDRESS_1>2nd Floor</ADDRESS_1>
<ADDRESS_2>28 Yongon-dong Chongno-gu</ADDRESS_2>
<CITY>Seoul</CITY>
<ZIP>110-744</ZIP>
<REGION/>
<COUNTRY CODE="KR">Korea, South</COUNTRY>
<PHONE_1>+82 2 740 8911</PHONE_1>
<PHONE_2>+82 2 3668 7019</PHONE_2>
<FAX_1>+82 2 743 8361</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-09 17:38:36 +0000" MODIFIED_BY="Harriet MacLehose">
<PERSON ID="14300" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Seokyung</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hahn</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor of Medical Statistics</POSITION>
<EMAIL_1>hahns@snu.ac.kr</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+82 10 2769 7549</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Medical Research Collaborating Center</DEPARTMENT>
<ORGANISATION>Seoul National University Hospital</ORGANISATION>
<ADDRESS_1>2nd Floor</ADDRESS_1>
<ADDRESS_2>28 Yongon-dong Chongno-gu</ADDRESS_2>
<CITY>Seoul</CITY>
<ZIP>110-744</ZIP>
<REGION/>
<COUNTRY CODE="KR">Korea, South</COUNTRY>
<PHONE_1>+82 2 740 8911</PHONE_1>
<PHONE_2>+82 2 3668 7019</PHONE_2>
<FAX_1>+82 2 743 8361</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14304" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Yaejean</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Kim</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>yjkim@fhcrc.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Infectious Diseases</DEPARTMENT>
<ORGANISATION>Fred Hutchinson Cancer Research Centre</ORGANISATION>
<ADDRESS_1>100 Fairview Avenue N</ADDRESS_1>
<ADDRESS_2/>
<CITY>Seattle</CITY>
<ZIP>WA 98109</ZIP>
<REGION/>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+206 667 2586</PHONE_1>
<PHONE_2/>
<FAX_1>+206 667 4411</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7492" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Paul</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Garner</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>pgarner@liv.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>International Health Group</DEPARTMENT>
<ORGANISATION>Liverpool School of Tropical Medicine</ORGANISATION>
<ADDRESS_1>Pembroke Place</ADDRESS_1>
<ADDRESS_2/>
<CITY>Liverpool</CITY>
<ZIP>L3 5QA</ZIP>
<REGION>Merseyside</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 151 705 3201</PHONE_1>
<PHONE_2/>
<FAX_1>+44 151 705 3364</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-09 18:13:20 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="28" MONTH="11" YEAR="2001"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="7" YEAR="2004"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2002"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-09 18:11:00 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-09 18:11:00 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format with minor editing.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-09 18:10:52 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-09 18:10:52 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="7" YEAR="2004"/>
<DESCRIPTION>
<P>New studies found but not yet included or excluded.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-09 18:10:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="11" YEAR="2001"/>
<DESCRIPTION>
<P>Changes made in response to feedback from specialists at the WHO/UNICEF oral rehydration salts formulation expert consultation. New York, 18 July 2001.</P>
<OL>
<LI>Seizures outcomes to be sought (changes in progress)</LI>
<LI>
<LINK REF="STD-Egypt-1996a" TYPE="STUDY">Egypt 1996a</LINK> testing maltodextran excluded</LI>
<LI>Secondary analysis stratifying by sodium levels (60 to 74, 75 to 85 mmol)</LI>
</OL>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Liverpool School of Tropical Medicine</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Medical and Pharmaceutical Statistics Research Unit, University of Reading</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Seoul National University Hospital</NAME>
<COUNTRY CODE="KR">Korea, South</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>World Health Organization</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Department for International Development</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-09 18:00:25 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-11-09 18:00:03 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-09 18:00:03 +0000" MODIFIED_BY="[Empty name]">Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children</TITLE>
<SUMMARY_BODY>
<P>Children with diarrhoea lose body water and sometimes become dehydrated. A solution of sugar and salt dissolved in water is widely used to treat dehydration caused by diarrhoea. This reviews shows that a solution of lower osmolarity than the current international standard means fewer children subsequently require an intravenous drip.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Oral rehydration solution (ORS) has reduced childhood deaths from diarrhoea in many countries. Recent studies suggest that the currently recommended formulation of ORS recommended by the World Health Organization (WHO) may not be optimal, and solutions that contain lower concentrations of sodium and glucose may be more effective.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare reduced osmolarity ORS with WHO standard ORS in children with acute diarrhoea.<BR/> </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>CENTRAL (<I>The Cochrane Library</I>, Issue 3, 2004), MEDLINE (1966 to July 2004), EMBASE (1988 to July 2004), and Current Contents (July 2004) were searched. Additional trials were identified by hand searching. Content experts were contacted. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomized controlled trials comparing reduced osmolarity ORS with the WHO standard ORS formulation. The primary outcome was unscheduled intravenous fluid infusion. Secondary outcomes were measures of clinical illness.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers extracted data. We tested for heterogeneity using the Chi-square statistic, conducted sensitivity analysis by allocation concealment, and the regression approach to assess funnel plot asymmetry from selective trial publication.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>The primary outcome, unscheduled intravenous fluid infusion, was reported in 11 trials. In a meta-analysis of 8 trials, reduced osmolarity ORS was associated with fewer unscheduled intravenous fluid infusions compared with WHO standard ORS (Mantel Haenzel odds ratio 0.59, 95% confidence interval 0.45 to 0.79) with no evidence for heterogeneity between trials. No unscheduled intravenous fluid infusion therapy was required in any participant in three trials. </P>
<P>Eleven trials reported stool output, and data suggested less stool output in the reduced osmolarity ORS group. Vomiting was less frequent in the reduced osmolarity group in the six trials reporting this. Six trials sought hyponatraemia, with events in three studies, but no obvious difference between the two arms.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>In children admitted to hospital with diarrhoea, reduced osmolarity ORS when compared to WHO standard ORS is associated with fewer unscheduled intravenous fluid infusions, lower stool volume post randomization, and less vomiting. No additional risk of developing hyponatraemia when compared with WHO standard ORS was detected. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-09 18:00:25 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Diarrhoea remains a leading cause of childhood death in middle and low income countries. The main complication is dehydration, which was treated with intravenous fluid infusion until the early 1960s. Oral rehydration solution (ORS) is now the mainstay of therapy and is particularly useful when intravenous fluids are in short supply, health services are basic, and there is a shortage of skilled personnel (<LINK REF="REF-Almroth-1995" TYPE="REFERENCE">Almroth 1995</LINK>). The combination of salt and sugar enhances fluid absorption because sodium and glucose transport in the small intestine are coupled, and glucose promotes absorption of both sodium ions and water (<LINK REF="REF-Fordtran-1968" TYPE="REFERENCE">Fordtran 1968</LINK>). Diarrhoea is caused by derangement of fluid absorption and secretion from the gut, and coupling sodium and glucose allows absorption, even during active fluid secretion due to infection. Thus rehydration can take place even with large fluid losses, as seen in enterotoxic diarrhoea, such as that caused by cholera or infection with Escherichia coli (<LINK REF="REF-Guarino-2001" TYPE="REFERENCE">Guarino 2001</LINK>). </P>
<P>ORS has proved both safe and effective worldwide in hospital settings, and is now widely used in the home to prevent dehydration (<LINK REF="REF-Mahalanabis-1973" TYPE="REFERENCE">Mahalanabis 1973</LINK>, <LINK REF="REF-Grant-1983" TYPE="REFERENCE">Grant 1983</LINK>).For more than two decades, the World Health Organization (WHO) has recommended the standard formulation of glucose-based ORS with 90 mmol/L of sodium and 111 mmol/L of glucose and a total osmolarity of 311 mmol/L. It remains unclear however, whether this is the optimum level of sodium. Laboratory work suggests that lower concentrations of sodium and glucose enhance solute induced water absorption (<LINK REF="REF-Farthing-1988" TYPE="REFERENCE">Farthing 1988</LINK>, <LINK REF="REF-Hunt-1992" TYPE="REFERENCE">Hunt 1992</LINK>). Papers report patients experiencing blood sodium levels above the normal of 150 mmol/L with standard solution (<LINK REF="REF-Finberg-1973" TYPE="REFERENCE">Finberg 1973</LINK>).</P>
<P>The objective of this review is to critically appraise and evaluate all relevant randomized controlled trials addressing comparative effects of reduced osmolarity ORS with WHO standard ORS. One potential adverse effect of reduced osmolarity ORS is a deficiency of sodium is the blood (hyponatraemia), which can give rise to convulsions. We are also exploring the risk of this adverse outcome through trial and observational data.</P>
<P>We confined the review to children, as they are most vulnerable to dehydration and electrolyte imbalance from diarrhoea, and are the targets for large primary care child investments that include ORS sachet distribution. Severity, duration, and volume of diarrhoea are often primary outcomes in clinical ORS studies, but we sought a pragmatic outcome relevant to health providers. ORS aims to rehydrate children and avoid the need for intravenous fluid infusion. We therefore identified unscheduled intravenous fluid infusion as a primary outcome as this represents failed oral therapy.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To compare reduced osmolarity oral rehydration solution with the World Health Organization recommended strength for treating diarrhoea in children.<BR/> </P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-09 18:00:24 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-11-09 18:00:24 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomized controlled trials, defined as a trial in which the subjects followed were assigned prospectively to one of two or more interventions by random allocation. This excludes quasi-randomized designs. </P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Children with acute diarrhoea (history of less than 5 days).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Experimental: Reduced osmolarity oral rehydration solution (total osmolarity 250 mmol/L or less with reduced sodium).</P>
<P>Control: World Health Organization standard oral rehydration solution (90 mmol/L sodium, 111mmol/L glucose, total osmolarity 311 mmol/L).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-09 18:00:24 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>Need for unscheduled intravenous fluid infusion during the course of treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<UL>
<LI>Stool output.</LI>
<LI>Children vomiting during rehydration.</LI>
<LI>Asymptomatic hyponatraemia (defined as serum sodium less than 130mmol/L) during follow up.</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>We used the following search terms to search all trial registers and electronic databases: child; diarrhoea; fluid therapy; oral rehydration; osmolar; and rehydration solutions. </P>
<P>We searched the following trial register: Cochrane Central Register of Controlled Trials (CENTRAL), published in <I>The Cochrane Library</I> (Issue 3, 2004).</P>
<P>We searched the following electronic databases: MEDLINE (1966 to July 2004); EMBASE (1988 to July 2004); and Current Contents (July 2004). </P>
<P>We also checked the citations of existing reviews and trial reports. </P>
<P>For unpublished data and ongoing trials, we contacted current researchers and key agencies, including the World Health Organization, the Centers for Disease Control and Prevention, Atlanta (USA), and the International Centre for Diarrhoeal Disease Research, Bangladesh. </P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-09 17:44:05 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-11-09 17:43:43 +0000" MODIFIED_BY="[Empty name]">
<P>SH and SK independently applied the inclusion criteria to all identified trials, and differences were resolved by discussion with the PG. </P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-10-22 11:34:22 +0100" MODIFIED_BY="[Empty name]">
<P>SH and SK extracted data on relevant outcome measures using a standardized data abstraction form.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-11-09 17:44:05 +0000" MODIFIED_BY="[Empty name]">
<P>Each included trial was assessed in terms of adequacy of concealment of allocation, generation of allocation sequence, blinding, and follow up of patients, using the guidelines of the Cochrane Infectious Diseases Group. Studies excluded were detailed in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'.</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-10-22 11:35:06 +0100" MODIFIED_BY="[Empty name]">
<P>We used the Mantel-Haenszel odds ratio (OR) for binary outcomes. The odds ratios were not estimated when neither intervention group found any event, which are indicated in the MetaView figures. We used the Standardized Mean Difference (SMD) for continuous outcomes. We combined studies using a fixed effect method. For all estimates, we calculated 95% confidence intervals. We tested statistical heterogeneity using Chi-square statistic with a P-value less than 0.1 indicating statistical significance. We had prespecified potential sources of heterogeneity for analysis. We examined publication bias using a funnel plot, and a regression approach (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) to assess funnel plot asymmetry. We conducted a sensitivity analysis in relation to adequate allocation concealment.</P>
<P>After presentation of the results, an expert consultation group from the World Health Organization recommended a stratified analysis by mmol sodium (less than 75 mmol and 75 to 85 mmol), and this analysis is now included (<LINK REF="REF-WHO-2001" TYPE="REFERENCE">WHO 2001</LINK>).</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-09 18:00:25 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-11-09 17:44:24 +0000" MODIFIED_BY="[Empty name]">
<P>We identified 41 studies for inclusion, and 16 studies met the inclusion criteria. The progress through the stages of meta-analysis, using the process suggested in the QUOROM statement (<LINK REF="REF-QUOROM-Group-1999" TYPE="REFERENCE">QUOROM Group 1999</LINK>), is shown below.</P>
<P>41 studies comparing oral rehydration solution (ORS) formulation for treating diarrhoea.<BR/>
</P>
<UL>
<LI>6 excluded as not randomized controlled trials (RCTs);</LI>
</UL>
<P>35 remaining RCTs of ORS comparing formulation for treating diarrhoea patients.<BR/>
</P>
<UL>
<LI>9 excluded as intervention was something other than reduced osmolarity ORS;</LI>
</UL>
<P>26 remaining RCTs reporting reduced osmolarity ORS in one treatment arm.<BR/>
</P>
<UL>
<LI>6 excluded if control group did not use World Health Organization (WHO) standard ORS;</LI>
</UL>
<P>20 remaining RCTs reporting comparison of reduced osmolarity ORS with WHO standard ORS.<BR/>
</P>
<UL>
<LI>2 excluded as not in children;</LI>
</UL>
<P>18 remaining RCTs reporting comparison of reduced osmolarity ORS with WHO standard ORS for treating children with diarrhoea.</P>
<UL>
<LI>2 excluded as no relevant outcomes reported;</LI>
</UL>
<P>16 remaining RCTs reporting comparison of reduced osmolarity ORS with WHO standard ORS in children with diarrhoea in relation to need of unscheduled intravenous fluid infusion therapy and some measures of clinical illness.</P>
<UL>
<LI>2 excluded (<LINK REF="STD-Mexico-1988" TYPE="STUDY">Mexico 1988</LINK>, <LINK REF="STD-Mexico-1990b" TYPE="STUDY">Mexico 1990b</LINK>) as they appear to be duplicates of a third trial (<LINK REF="STD-Mexico-1990a" TYPE="STUDY">Mexico 1990a</LINK>). We have contacted the authors, but while awaiting clarification, we have included only the paper with the largest number of patients (<LINK REF="STD-Mexico-1990a" TYPE="STUDY">Mexico 1990a</LINK>).</LI>
</UL>
<P>13 remaining RCTs. As one paper reported on two trials, one in the USA and one in Panama, we present these as separate studies (<LINK REF="STD-Panama-1982" TYPE="STUDY">Panama 1982</LINK>, <LINK REF="STD-USA-1982" TYPE="STUDY">USA 1982</LINK>).</P>
<P>This leaves a total of 14 included studies. These were from Egypt (2), Bangladesh (3), Mexico (1), Colombia (1), India (3), Panama (1), and the USA (1). Two other studies were multicentre trials; one was conducted in Brazil, India, Mexico, and Peru, and the other in Bangladesh, Brazil, India, Peru, and Vietnam.</P>
<P>Participants were children with acute non-cholera diarrhoea in all trials except three, which included cholera patients (<LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>). In all but one which included children up to 5 years old (<LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>), the participants' ages ranged between 1 and 36 months. All children had some degree of clinical dehydration. One trial treated all children on day 1 with intravenous fluid infusion, and those still producing 80 ml/kg/24h were then randomized (<LINK REF="STD-Bangladesh-1995a" TYPE="STUDY">Bangladesh 1995a</LINK>). In five trials (<LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>, <LINK REF="STD-Panama-1982" TYPE="STUDY">Panama 1982</LINK>, <LINK REF="STD-WHO-1995" TYPE="STUDY">WHO 1995</LINK>, <LINK REF="STD-USA-1982" TYPE="STUDY">USA 1982</LINK>) severely dehydrated children were included. Five trials included malnourished children (<LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-Colombia-2000" TYPE="STUDY">Colombia 2000</LINK>, <LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>, <LINK REF="STD-Mexico-1990a" TYPE="STUDY">Mexico 1990a</LINK>). The number of breastfed children was reported in eight trials (<LINK REF="STD-Bangladesh-1995a" TYPE="STUDY">Bangladesh 1995a</LINK>, <LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-Bangladesh-1996a" TYPE="STUDY">Bangladesh 1996a</LINK>, <LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-Colombia-2000" TYPE="STUDY">Colombia 2000</LINK>, <LINK REF="STD-Egypt-1996b" TYPE="STUDY">Egypt 1996b</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>, <LINK REF="STD-WHO-1995" TYPE="STUDY">WHO 1995</LINK>). Fully weaned children were included in one trial (<LINK REF="STD-Egypt-1994" TYPE="STUDY">Egypt 1994</LINK>).</P>
<P>We deviated slightly from the osmolarity definitions in our peer refereed protocol published in The Cochrane Library. For reduced osmolarity, we had defined this to be lower than 250 mmol/L, but some studies defined this as higher, and we therefore extended our limit to a total osmolarity of 270 mmol/L. For the WHO standard ORS, defined as a total osmolarity of 311 mmol/L, we also included two studies that used a slightly different WHO standard ORS with a total osmolarity of 331 mmol/L but with the same sodium and glucose combination (<LINK REF="STD-Panama-1982" TYPE="STUDY">Panama 1982</LINK>, <LINK REF="STD-USA-1982" TYPE="STUDY">USA 1982</LINK>). All but two trials used a glucose based reduced osmolarity ORS; one used sucrose (Bangladesh 1996a), and one used L-alanine with glucose (<LINK REF="STD-Bangladesh-1995a" TYPE="STUDY">Bangladesh 1995a</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-09 17:44:53 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Allocation</HEADING>
<P>All of the studies were randomized controlled trials. Nine reported methods that assured adequate allocation concealment (<LINK REF="STD-WHO-1995" TYPE="STUDY">WHO 1995</LINK>, <LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-Colombia-2000" TYPE="STUDY">Colombia 2000</LINK>, <LINK REF="STD-Egypt-1996b" TYPE="STUDY">Egypt 1996b</LINK>, <LINK REF="STD-Bangladesh-1995a" TYPE="STUDY">Bangladesh 1995a</LINK>, <LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-Bangladesh-1996a" TYPE="STUDY">Bangladesh 1996a</LINK>, <LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding</HEADING>
<P>Six studies (<LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-Egypt-1996b" TYPE="STUDY">Egypt 1996b</LINK>, <LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-Bangladesh-1996a" TYPE="STUDY">Bangladesh 1996a</LINK>, <LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>) were double blinded. One of the Mexico studies was described as single blinded (<LINK REF="STD-Mexico-1990b" TYPE="STUDY">Mexico 1990b</LINK>), but this study is currently excluded from the analysis as it is thought to be a subset of patients reported in another paper which is included, where no details of blinding are given (<LINK REF="STD-Mexico-1990a" TYPE="STUDY">Mexico 1990a</LINK>). Eight studies did not mention blinding.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Inclusion of all randomized participants</HEADING>
<P>Included trials had losses to follow up of less than 10% of randomized participants in all cases.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-09 18:00:25 +0000" MODIFIED_BY="[Empty name]">
<P>Meta-analyses of the four outcomes are illustrated in the MetaView summary analysis.</P>
<P>Information for the primary outcome of the need for unscheduled intravenous fluid infusion was found in 11 trials (n = 1996). In the meta-analysis of 8 trials, a statistically significant reduction for unscheduled intravenous infusion for participants receiving reduced osmolarity oral rehydration solution (ORS) when compared with World Health Organization (WHO) standard ORS was demonstrated (odds ratio 0.59, 95% confidence interval 0.45 to 0.79). 3 of the 11 trials reported that none of their patients needed intravenous fluid infusion in either group, and the odds ratios were not calculated for these trials.</P>
<P>11 trials reported stool output during rehydration. These trials measured stool output in various ways using different units. We therefore used the standardized mean difference to analyse these data. Since the stool output in diarrhoeal disease showed a positive skewed distribution with clinical improvement, we used a log-normal approximation. The pooled standardized mean difference in the log scale is -0.23 (95% confidence interval -0.33 to -0.14), which suggests that the reduced osmolarity ORS resulted in significantly less stool output when compared with the WHO standard ORS. Data from one trial (<LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>) were not combined with the others in the meta-analysis because this trial measured stool output for a much longer period beyond rehydration phase. The individual results of all 12 trials are summarized in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For children vomiting during rehydration, six trials reported these data. The tendency was for fewer patients to vomit in the reduced osmolarity ORS group (Odds ratio 0.71, 95% confidence interval 0.55 to 0.92).</P>
<P>For presence of hyponatraemia, six trials reported this outcome. Three of these six trials did not observe hyponatraemia in any participants, irrespective of their allocated group. The meta-analysis of three trials, during which participants developed hyponatraemia, showed no significant difference between the groups (odds ratio 1.45, 95% confidence interval 0.93 to 2.26).</P>
<P>We tested for statistical heterogeneity of treatment effect across trials using the Chi-square statistic for all meta-analyses, and the statistic is presented in each meta-analysis diagram. Results suggest no evidence of statistical heterogeneity (P-value &gt; 0.1) for any outcome considered.</P>
<P>A funnel plot was prepared with the primary outcome. The regression method used to assess funnel plot asymmetry yielded an intercept of -0.104 with a P-value of 0.12, indicating no significant evidence of publication bias.</P>
<P>Sensitivity analysis carried out included studies where allocation concealment was clearly described as adequate and suggested little difference from the original meta-analysis. For example, the pooled odds ratios of the seven trials for the primary outcome with adequate allocation concealment was 0.61 (95% confidence interval 0.46 to 0.82).</P>
<P>A stratified analysis by sodium content of the ORS is presented. Hyponatraemia was not detected in the three studies examining the very low sodium ORS.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>We intended to examine treatment effects in cholera subgroup compared with non-cholera diarrhoea. A Cochrane Review of rice-based rehydration compared with glucose oral rehydration solution (ORS) showed that rice water was associated with lower stool volumes in cholera patients but not in diarrhoea from other causes (<LINK REF="REF-Fontaine-2000" TYPE="REFERENCE">Fontaine 2000</LINK>). The available data were insufficient however. Three studies (<LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>, <LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>, <LINK REF="STD-India-2000b" TYPE="STUDY">India 2000b</LINK>) involved cholera patients, but a subgroup analysis for cholera patients was not available for meta-analysis. There were two studies (<LINK REF="REF-Farugue-1996" TYPE="REFERENCE">Farugue 1996</LINK>, <LINK REF="REF-Alam-1999" TYPE="REFERENCE">Alam 1999</LINK>) in patients with cholera excluded from this review because they were in adults. Any recommendation for rehydration treatment for adults with cholera will need to take these and any other trials found through careful systematic searching into account. </P>
<P>This review examines trials of children admitted to hospital who were dehydrated because of diarrhoea. The trials do not provide any direct evidence for or against the use of ORS at home to prevent dehydration developing; nor do they provide any direct evidence that reduced osmolarity ORS is more effective in preventing dehydration in home-based care in this group.</P>
<P>We stand by our selection of unscheduled intravenous fluid infusion rather than volume of diarrhoea as the primary outcome, as specified in the original protocol. Some specialists consider that volume of diarrhoea is more appropriate, probably because it reflects the animal and human perfusion experiments that provide part of the rationale for a reduced osmolarity ORS. Unscheduled intravenous fluid infusion is pragmatic; it provides a measure of failed oral rehydration and has implications for the healthcare resources. For these reasons, we preserved this as the primary outcome. </P>
<P>When we reviewed the studies for inclusion, most trials reported unscheduled intravenous fluid infusion in the details of trial implementation, where exclusions and dropouts were described. As this was identified as our primary outcome at the protocol stage, we sought out these data and presented them as the primary analysis, and it is our opinion this shows a clear effect. This highlights the value for careful attention to the protocol for a systematic review before examining the trials, and provides an illustration of how non-specialist viewpoints can actually help in obtaining practical and useful answers from meta-analysis.</P>
<P>We found that reduced osmolarity ORS has beneficial effects over the WHO standard ORS in reducing needs for unscheduled intravenous fluid infusion, stool output during rehydration, and the number of patients with vomiting during oral rehydration treatment. Reduced osmolarity ORS has no further risk of developing hyponatraemia as compared to the WHO standard ORS. We are currently exploring the feasibility of obtaining data on convulsions (as evidence of symptomatic hyponatraemia) for the authors of the largest trial (<LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>).</P>
<P>The research evidence presented here relates to the ORS used for treating children with dehydration. ORS is used much more widely for preventing dehydration developing in children with diarrhoea. While this seems appropriate, the applicability to prevention is a judgement, and highlights the need for a systematic review to examine the policies of ORS provision and ORS formula in preventing dehydration in children with diarrhoea.</P>
<P>Findings from this review indicate reduced osmolarity ORS is more effective than WHO standard ORS in the first line treatment of dehydration in children with diarrhoea. It is not easy to be sure however, that this finding applies to a subgroup of patients with severe diarrhoea caused by cholera, where electrolyte loss is profound. This could increase the risk of hyponatraemia, result in adverse clinical events, and attenuate the advantages of reduced osmolarity ORS.</P>
<P>There is the possibility that policymakers and clinicians will judge that cholera reverses the balance of benefits and harms (that is, hyponatraemia will be more common, and outweigh the advantages of reduced osmolarity solution). If this is the case, then one option is to provide WHO standard ORS for people with suspected cholera, or in areas where cholera is prevalent. This is likely to be a logistical problem in areas where diarrhoea is common and coexists with cholera. The single formula sachet aids implementation of this lifesaving intervention. Providing different formulations complicates distribution. It means health workers have a more complicated task in providing the appropriate ORS. These factors may actually impair the effective delivery of any ORS to children. </P>
<P>Policymakers need to be careful if they decide against change a shift to reduced osmolarity solution in areas where cholera is common because of a putative risk around hyponatraemia. If they do this, then they are obliged to prove or disprove their belief in the superiority of WHO standard ORS through a randomized controlled trial in children with clinical cholera. The WHO has convened a expert working group to consider this review and related evidence. The group recommended that ORS for treating diarrhoea in children with non-cholera diarrhoea will be enhanced by shifting to a reduced osmolarity ORS, and propose a global shift to ORS with an osmolarity of 75 mEq/L of sodium (<LINK REF="REF-WHO-2001" TYPE="REFERENCE">WHO 2001</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Oral rehydration solution (ORS) has saved many children's lives in low and middle income countries, and the sachets are widely used in primary care, based on standards set by the World Health Organization (WHO). This review summarized data from existing studies, and provide some evidence that dehydrated children given a solution with a lower osmolarity were less likely to need an intravenous infusion than those given WHO standard ORS. These results have important implications for policy, and WHO and UNICEF, based on this review, related data, and expert discussions, are recommending reduced osmolarity ORS be accepted as standard (<LINK REF="REF-WHO-2001" TYPE="REFERENCE">WHO 2001</LINK>).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>We found insufficient data on cholera in children to make recommendations for this condition. Since cholera is a secretory diarrhoea and electrolyte loss is profound, if reduced osmolarity ORS is to be used in cholera, more trials to investigate this should be undertaken.</P>
<P>There is a need for a good systematic review examining the influence of policies of ORS provision in preventing dehydration and hospital admissions in children with diarrhoea.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>To: Christopher Duggan; Olivier Fontaine; Sheila Bird for comments. We note that the data presented and the views expressed are entirely the responsibility of the authors.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-11-09 17:59:52 +0000" MODIFIED_BY="[Empty name]">
<P>We certify that we have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of the review (eg employment, consultancy, stock ownership, honoraria, expert testimony).</P>
<P>The World Health Organization provided funds for us to conduct this review.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Seokyung Hahn and Yaejean Kim wrote the protocol, conducted the data extraction, data analysis and interpretation, and drafted the paper. Paul Garner advised on inclusion criteria and outcomes for the protocol, quality assessment and analysis, and helped write the review. Paul Garner is the guarantor.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2008-11-09 17:45:32 +0000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-09 18:03:48 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-10-22 13:06:02 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1995a" NAME="Bangladesh 1995a" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saker SA, Majid N, Mahalanabis D</AU>
<TI>Alanine- and glucose-based hypo-osmolar oral rehydration solution in infants with persistent diarrhoea: a controlled trial</TI>
<SO>Acta Paediatrica</SO>
<YR>1995</YR>
<VL>84</VL>
<PG>775-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1995b" NAME="Bangladesh 1995b" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahalanabis D, Faruque ASG, Hoque SS, Faruque SM</AU>
<TI>Hypotonic oral rehydration solution in acute diarrhoea: a controlled clinical trial</TI>
<SO>Acta Paediatrica</SO>
<YR>1995</YR>
<VL>84</VL>
<PG>289-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1996a" NAME="Bangladesh 1996a" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faruque ASG, Mahalanabis D, Hamadani J, Hoque SS</AU>
<TI>Hypo-osmolar sucrose oral rehydration solution in acute diarrhoea: a pilot study</TI>
<SO>Acta Paediatrica</SO>
<YR>1996</YR>
<VL>85</VL>
<PG>1247-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-CHOICE-2001" NAME="CHOICE 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>CHOICE study group</AU>
<TI>Multicenter randomized double blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration solution in children with acute watery diarrhoea</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<PG>613-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colombia-2000" NAME="Colombia 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Corresponding author: C Bernal, Pediatrics &amp;amp; Puericulture Department, University of Antioquia. Apartado Aereo 1226. Medellin. Colombia. Telephone 2637885. Email: cabp@epm.net.co&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernal C, Velasquez C, Garcia G, Uribe G, Palacio C</AU>
<TI>Oral rehydration with a low-osmolarity solution in children dehydrated by diarrheric diseases. A controlled clinical study</TI>
<TO>Hidratacion oral con una solucion de baja osmolaridad en ninos deshidratados por enfermedades diarreicas: un estudio clinico controlado</TO>
<SO>Saludarte</SO>
<YR>2000</YR>
<VL>1</VL>
<PG>6-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Egypt-1994" NAME="Egypt 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Mougi M, El-Akkad N, Hendawi A, Hassan M, Amer A, Fontaine O, Pierce N F</AU>
<TI>Is a low-osmolarity ORS solution more efficacious than standard WHO ORS solution?</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>1</NO>
<PG>83-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Egypt-1996b" NAME="Egypt 1996b" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Fayad I, Zikiri MA, Hussein A, Amponsah A, Duggan C, et al</AU>
<TI>A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose</TI>
<SO>Journal of Pediatrics</SO>
<YR>1996</YR>
<VL>128</VL>
<NO>1</NO>
<PG>45-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-1984a" NAME="India 1984a" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhargava SK, Sachdev HP, Das Gupta B, Daral TS, Singh HP, Mohan M</AU>
<TI>Oral rehydration of neonates and young infants with dehydration diarrhea: compararison of low and standard sodium content in oral rehydration solutions</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1984</YR>
<VL>3</VL>
<NO>4</NO>
<PG>500-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="85009156"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-2000a" NAME="India 2000a" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dutta P, Dutta S, Manna B, Chatterjee MK, De A, Bhattacharya SK</AU>
<TI>Hypo-osmolar oral rehydration salts solution in dehydrating persistent diarrhoea in children: double-blind, randomized, controlled clinical trial</TI>
<SO>Acta Paediatrica</SO>
<YR>2000</YR>
<VL>89</VL>
<PG>411-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-2000b" NAME="India 2000b" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alam S, Afzal K, Maheshwari M, Shukia I</AU>
<TI>Controlled trial of hypo-osmolar versus World Health Organization oral rehydration solution</TI>
<SO>Indian Pediatrics</SO>
<YR>2000</YR>
<VL>37</VL>
<PG>952-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mexico-1990a" NAME="Mexico 1990a" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreno-Sanchez H, Velasques-Jones L, Becerra FC, Faure A, Maulen I, Leon M de, et al</AU>
<TI>A comparative study on two oral rehydration solutions(ORS) containing 60 or 90 mmol/L of sodium and of different osmolalities</TI>
<TO>Estudio comparativo de dos soluciones de hidratacion oral conteniendo 60 o 90 mmol/L de sodio y con diferente osmolalidad</TO>
<SO>Boletin Medico del Hospital Infantil de Mexico</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>9</NO>
<PG>630-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Panama-1982" NAME="Panama 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Daum L Dillman RS, Rodriguez JL, Luque S, Russel R, et al</AU>
<TI>Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama</TI>
<SO>New England Journal of Medicine</SO>
<YR>1982</YR>
<VL>306</VL>
<NO>18</NO>
<PG>1070-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1982" NAME="USA 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Daum L, Dillman RS, Rodriguez JL, Luque S, Russel R, et alA, Benenson AS, Sack RB</AU>
<TI>Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama</TI>
<SO>New England Journal of Medicine</SO>
<YR>1982</YR>
<VL>306</VL>
<NO>18</NO>
<PG>1070-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-WHO-1995" NAME="WHO 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>International Study Group on Reduced-osmolarity ORS solutions</AU>
<TI>Multicentre evaluation of reduced-osmolarity oral rehydration salts solution</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>345</VL>
<PG>282-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-10-22 13:06:02 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Australia-1990" NAME="Australia 1990" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cleghorn GJ, Shepherd RW, Patrick MK</AU>
<TI>Comparison of two oral rehydration solutions in children with gastroenteritis in Australia</TI>
<SO>Clinical Therapeutics</SO>
<YR>1990</YR>
<VL>12 Suppl A</VL>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Australia-1993" NAME="Australia 1993" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wall CR, Shepherd RW, Patric M, Chin S, Cleghorn G</AU>
<TI>Osmolality electrolyte and carbohydrate type and oral rehydration solutions: A controlled study to compare the efficacy of two commercially available solutions(osmolalities 240 mmol/L and 34 mmol/L)</TI>
<SO>Journal of Diarrhoeal Diseases Research</SO>
<YR>1993</YR>
<VL>11</VL>
<NO>4</NO>
<PG>222-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1978" MODIFIED="2008-10-22 13:06:02 +0100" MODIFIED_BY="[Empty name]" NAME="Bangladesh 1978" YEAR="">
<REFERENCE MODIFIED="2008-10-22 13:06:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sack DA, Chowdhury AMAK, Eusof A, Ali MA, Merson MH, Islam S, et al</AU>
<TI>Oral hydration in rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution</TI>
<SO>Lancet</SO>
<YR>1978</YR>
<VL>2</VL>
<PG>280-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1991" NAME="Bangladesh 1991" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akbar MS, Baker KM, Aziz MA, Khan WA, Salim AFM</AU>
<TI>A randomised, double-blind clinical trial of a maltodextrin containing oral rehydration solution in acute infantile diarrhoea</TI>
<SO>Journal of Diarrhoeal Diseases Research</SO>
<YR>1991</YR>
<VL>9</VL>
<NO>1</NO>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1996b" NAME="Bangladesh 1996b" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faruque D, Mahalanabis ASG, Hamadani v, Zetterstrom JD</AU>
<TI>Reduced ormolarity oral rehydration salt in cholera</TI>
<SO>Scand Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>28</VL>
<PG>87-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bangladesh-1999" NAME="Bangladesh 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alam NH, Majumder RN, Fuchs GJ, CHOICE group</AU>
<TI>Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>296-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Costa-Rica-1987" NAME="Costa Rica 1987" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pizarro D, Castillo B, Posada G, Lizano C, Mata L</AU>
<TI>Efficacy comparison of oral rehydration solutions containing either 90 or 75 millimoles of sodium per liter</TI>
<SO>Pediatrics</SO>
<YR>1987</YR>
<VL>79</VL>
<NO>2</NO>
<PG>190-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ecuador-1995" NAME="Ecuador 1995" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barclay DV, Gil-Ramos J, Mora JO, Dirren H</AU>
<TI>A packaged rice-based oral rehydration solution for acute diarrhea</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1995</YR>
<VL>20</VL>
<NO>4</NO>
<PG>408-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Egypt-1996a" NAME="Egypt 1996a" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Mougi M, Hendawi A, Koura H, Hegazi E, Fontaine O, Pierce NF</AU>
<TI>Efficy of standard glucose-based and reduced osmolarity maltodextrin-based oral rehydration solution: effect of sugar malabsorption</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>1996</YR>
<VL>74</VL>
<NO>5</NO>
<PG>471-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1985" NAME="Finland 1985" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isolauri E</AU>
<TI>Evaluation of an oral rehydration solution with Na 60 mmol/l in infants hospitalized for acute diarrhoea or treated as outpatients</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1985</YR>
<VL>74</VL>
<PG>643-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1986" NAME="Finland 1986" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vesikari T, Isolauri E</AU>
<TI>Glycine supplemented oral rehydration solutions for diarrhoea</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1986</YR>
<VL>61</VL>
<PG>372-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1993" NAME="Finland 1993" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rautanen T, El-RAdhi S, Vesikari T</AU>
<TI>Clinical experience with a hypotonic oral rehydration solution in acute diarrhoea</TI>
<SO>Acta Paediatrica</SO>
<YR>1993</YR>
<VL>82</VL>
<PG>52-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1997" NAME="Finland 1997" YEAR="">
<REFERENCE NOTES="&lt;p&gt;Standard ORS was not WHO solution. Two solutions had same amount of sodium, 60 mmol/L&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rautane T, Kurki S, Vesikari T</AU>
<TI>Randomised double blind study of hypotonic oral rehydration solution in diarrhoea</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1997</YR>
<VL>76</VL>
<PG>272-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1998" NAME="Finland 1998" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rautanen T, Isolauri E, Salo E, Vesikari T</AU>
<TI>Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1998</YR>
<VL>79</VL>
<PG>157-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-France-1990" NAME="France 1990" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mallet E, Guillot M, Le Luyer B, Morin C, Pollet F, De Meynard C</AU>
<TI>Comparison of two oral rehydration solutions in eutrophic infants with moderate acute diarrhea: results of an interim analysis</TI>
<SO>Clinical Therapeutics</SO>
<YR>1990</YR>
<VL>12 Suppl A</VL>
<PG>104-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guinea_x002d_Bissau-1999" NAME="Guinea-Bissau 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valentiner-Branth P, Steinsland H, Gjessing HK, Santos G, Bhan MK, Dias F, et al</AU>
<TI>Community-based randomized controlled trial of reduced osmolarity oral rehydration solution in acute childhood diarrhea</TI>
<SO>Pediatric Infectious Diseases Journal</SO>
<YR>1999</YR>
<VL>18</VL>
<PG>789-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-1978" NAME="India 1978" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chatterjee A, Mahalanabis D, Jalan KN, Maitra TK, Agarwal SK, Dutta B, et al</AU>
<TI>Oral rehydration in infantile diarrhoea</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1978</YR>
<VL>53</VL>
<PG>284-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-1984b" NAME="India 1984b" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Partra FC, Mahalanabis D, Jalan KN, Sen A, Banerjee P</AU>
<TI>In search of a super solution: controlled trial of glycin-glucose oral rehydration solution in infantile diarrhoea</TI>
<SO>Acta Paediatrica Scandanavica</SO>
<YR>1984</YR>
<VL>73</VL>
<PG>18-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iran-1983" NAME="Iran 1983" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saberi MS, Assaee M</AU>
<TI>Oral hydration of diarrhoeal dehydration : Comparison of high and low sodium concentration in rehydration solutions</TI>
<SO>Acta Paediatrica Scandanavica</SO>
<YR>1983</YR>
<VL>72</VL>
<PG>167-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mexico-1988" NAME="Mexico 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez-Pantaleon 0, Faure-Vilchis A, Gomez-Najera RI, Hernandez-Lopez M, Velasquez-Jones L</AU>
<TI>Comparative study of oral rehydration solutions containing either 90 or 60 millimoles of sodium per liter.</TI>
<TO>Estudio comparativo de dos soluciones de rehidratacion oral conteniendo 90 o 60 milimoles de sodio por litro</TO>
<SO>Boletin Medico del Hospital Infantil de Mexico</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>12</NO>
<PG>817-22</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="89193920"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mexico-1990b" NAME="Mexico 1990b" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Velasquez-Jones L, Becerra F, Faure A, de Leon M, Moreno H, Maulen I, et al</AU>
<TI>Clinical experience in Mexico with a new oral rehydration solution with lower osmolality</TI>
<SO>Clinical Therapeutics</SO>
<YR>1990</YR>
<VL>12 Suppl A</VL>
<PG>95-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myanmar-1991" NAME="Myanmar 1991" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khin-Maunh-U, Myo-Khin, Nyunt-Nyunt-Wai, Mu-Mu-Khin, Mya-Thi, Thein-Thein-Myint</AU>
<TI>Comparison of glucose/elctrolyte and maltodextrin/glycine/glycyl-glycine/electrolye oral rehydration solution in acute diarrhea in children</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>1992</YR>
<VL>13</VL>
<PG>397-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Russia-1997" NAME="Russia 1997" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari R</AU>
<TI>A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea</TI>
<SO>Acta Paediatrica</SO>
<YR>1997</YR>
<VL>86</VL>
<PG>460-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turkey-1985" NAME="Turkey 1985" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sokucu S, Marin L, Gunoz H, Aperia A, Neyzi O, Zetterstrom R</AU>
<TI>Oral rehydration therapy in infectious diarrhoea. Comparison of rehydration solutions with 60 and 90 mmol sodium per litre</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1985</YR>
<VL>74</VL>
<PG>489-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Turkey-1986" NAME="Turkey 1986" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marin L, Gunoz H, Sokucu S, Saner G, Aperia A, Neyzi O, et al</AU>
<TI>Oral rehydration therapy in malnourished infants with infectious diarrhoea</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1986</YR>
<VL>75</VL>
<PG>477-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1972" NAME="USA 1972" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hirschhorn N, Cash RA, Woodward WE, Spivey GH</AU>
<TI>Oral fluid therapy of Apache children with acute infectious diarrhoea</TI>
<SO>Lancet</SO>
<YR>1972</YR>
<VL>7766</VL>
<PG>15-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1986" NAME="USA 1986" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santosham M, Burns BA, Reid R, Letson W, Duncan B, Powlesland JA, et al</AU>
<TI>Glycine-based oral rehydration solutioin: reassessment of safety and efficacy</TI>
<SO>Jounal of Pediatrics</SO>
<YR>1986</YR>
<VL>109</VL>
<NO>5</NO>
<PG>795-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-09 18:03:48 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-09 18:03:48 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alam-1999" NAME="Alam 1999" TYPE="JOURNAL_ARTICLE">
<AU>Alam NH, Majumder RN, Fuchs GJ, CHOICE study group</AU>
<TI>Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blinded clinical trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>296-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Almroth-1995" NAME="Almroth 1995" TYPE="JOURNAL_ARTICLE">
<AU>Almroth S, Latham MC</AU>
<TI>Rational home management of diarrhoea</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>345</VL>
<PG>709-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analyses detected by a simple graphical test</TI>
<SO>British Medical Journal</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Farthing-1988" NAME="Farthing 1988" TYPE="JOURNAL_ARTICLE">
<AU>Farthing MJ</AU>
<TI>History and rationale of oral rehydration and recent develpments in formulating an optimal solution</TI>
<SO>Drugs</SO>
<YR>1988</YR>
<VL>36 Suppl 4</VL>
<PG>80-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Farugue-1996" NAME="Farugue 1996" TYPE="JOURNAL_ARTICLE">
<AU>Faruque ASG, Mahalanabis D, Hamadani JD, Zetterstrom R</AU>
<TI>Reduced osmoloarity oral rehydration salt in cholera</TI>
<SO>Scandanavian Journal of Infectious Diseases</SO>
<YR>1996</YR>
<VL>28</VL>
<PG>87-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Finberg-1973" NAME="Finberg 1973" TYPE="JOURNAL_ARTICLE">
<AU>Finberg L</AU>
<TI>Hypernatremic (hypertonic) dehydration in infants</TI>
<SO>New England Journal of Medicine</SO>
<YR>1973</YR>
<VL>289</VL>
<PG>196-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fontaine-2000" MODIFIED="2008-10-22 13:23:05 +0100" MODIFIED_BY="[Empty name]" NAME="Fontaine 2000" TYPE="COCHRANE_REVIEW">
<AU>Fontaine O, Gore SM, Pierce NF</AU>
<TI>Rice-based oral rehydration solution for treating diarrhoea (Cochrane Review)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2008-10-22 13:15:12 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-22 13:15:08 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fordtran-1968" NAME="Fordtran 1968" TYPE="JOURNAL_ARTICLE">
<AU>Fordtran JS, Rector FC, Carter NW</AU>
<TI>The mechanisms of sodium absorption in the human small intestine</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1968</YR>
<VL>47</VL>
<PG>884-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grant-1983" MODIFIED="2008-10-22 13:21:10 +0100" MODIFIED_BY="[Empty name]" NAME="Grant 1983" TYPE="BOOK_SECTION">
<AU>Grant JP</AU>
<TI>The state of the world's children 1982-1983</TI>
<SO>UNICEF</SO>
<YR>1983</YR>
<PB>UNICEF</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guarino-2001" NAME="Guarino 2001" TYPE="JOURNAL_ARTICLE">
<AU>Guarino A, Albano F, Guandalini S</AU>
<TI>Oral rehydration: Toward a real solution</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>2001</YR>
<VL>33 Suppl 4</VL>
<PG>2-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunt-1992" NAME="Hunt 1992" TYPE="JOURNAL_ARTICLE">
<AU>Hunt JB, Elliotte EJ, Fairclough PD, Clark ML, Farthing MJ</AU>
<TI>Water and solute absorption from hypotonic glucose-electrolyte solutions in human jejunum</TI>
<SO>Gut</SO>
<YR>1992</YR>
<VL>33</VL>
<NO>4</NO>
<PG>479-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mahalanabis-1973" NAME="Mahalanabis 1973" TYPE="JOURNAL_ARTICLE">
<AU>Mahalanabis M, Choudfuri AB, Bagchi NG</AU>
<TI>Oral fluid therapy of cholera among Bangladesh refugees</TI>
<SO>Johns Hopkins Med J</SO>
<YR>1973</YR>
<VL>132</VL>
<PG>197-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-QUOROM-Group-1999" NAME="QUOROM Group 1999" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Cook DJ, Eastwood S, Okin I, Rennie D, Stroup DF, for the Quorum Group</AU>
<TI>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>1896-1900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2001" NAME="WHO 2001" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Expert consultation on oral rehydration salts (ORS) formulation</TI>
<SO>Child and Adolescent Health and Development</SO>
<YR>2001</YR>
<VL>WHO/FCH/CAH/01.22</VL>
<PG>[18 July 2001]</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Hahn-2001" NAME="Hahn 2001" TYPE="JOURNAL_ARTICLE">
<AU>Hahn S, Kim Y, Garner P</AU>
<TI>Reduced osmolarity oral rehydration salts solution for treating diarrhoea-associated dehydration in children: systematic review</TI>
<SO>British Medical Journal</SO>
<YR>2001</YR>
<VL>323</VL>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-09 17:59:51 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-11-09 17:59:51 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-11-09 17:59:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bangladesh-1995a">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:50:18 +0100" MODIFIED_BY="[Empty name]">
<P>55 children 2 to 15 months old</P>
<P>Randomized after 1 day of rehydration</P>
<P>Dehydration status not known</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 17:59:51 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low L-alanine and glucose ORS (255 mosmol/L)</LI>
<LI>IV</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 17:59:50 +0000" MODIFIED_BY="[Empty name]">
<P>Stool output (24 h, 96 h)</P>
<P>Unscheduled IV</P>
<P>Fluid intake</P>
<P>Food intake</P>
<P>Vomiting</P>
<P>Body weight</P>
<P>Stool frequency</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:45:54 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bangladesh-1995b">
<CHAR_METHODS>
<P>RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:50:33 +0100" MODIFIED_BY="[Empty name]">
<P>50 children 5 to 24 months old with diarrhoea and mild to moderate dehydration</P>
<P>Some with cholera</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:51:30 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (249 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:50:39 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (24 h, 48 h)</P>
<P>Stool frequency</P>
<P>Fluid intake</P>
<P>Patients vomiting</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:14 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bangladesh-1996a">
<CHAR_METHODS>
<P>RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:50:44 +0100" MODIFIED_BY="[Empty name]">
<P>46 children 6 to 30 months with diarrhoea and mild to moderate dehydration (WHO)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:51:46 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity sucrose ORS (198 mosmol/L after full hydrolysis -&gt; 257 mosm/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:51:50 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (24h, 48 h)</P>
<P>ORS intake</P>
<P>Unscheduled IV</P>
<P>Urine output</P>
<P>Stool frequency</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:17 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-CHOICE-2001">
<CHAR_METHODS>
<P>RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>671 children <BR/>1 to 24 months old with diarrhoea and some more severe dehydration.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:51:54 +0100" MODIFIED_BY="[Empty name]">
<P>(1) Low osmolarity glucose ORS<BR/>(245 mosmol/L)</P>
<P>(2) WHO standard ORS</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:52:00 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (24 h and total)</P>
<P>ORS intake (24 h, total)</P>
<P>Vomiting in first 24 h</P>
<P>Unscheduled IV in the first 24 h</P>
<P>Frequency of hyponatraemia at 24 h</P>
<P>Duration of diarrhoea</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:21 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Colombia-2000">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:52:03 +0100" MODIFIED_BY="[Empty name]">
<P>140 boys 1 to 36 months old with diarrhoea and mild or moderate dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:52:24 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (245 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:52:08 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output rate at 24 h</P>
<P>Fluid and food intake</P>
<P>Weight gain</P>
<P>Sodium and potassium levels</P>
<P>Urine and vomit outputs</P>
<P>Vomiting</P>
<P>Unscheduled IV</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:25 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Egypt-1994">
<CHAR_METHODS MODIFIED="2008-10-22 11:52:30 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, no details given</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:52:31 +0100" MODIFIED_BY="[Empty name]">
<P>61 children 3 to 24 months old with diarrhoea and moderate dehydration (WHO definition)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:52:59 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (210 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
<LI>IV infusion</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:52:38 +0100" MODIFIED_BY="[Empty name]">
<P>Stool volume at 24 h</P>
<P>Fluid intake</P>
<P>Weight gain at 6 h</P>
<P>Hyponatraemia;</P>
<P>Duration of diarrhoea</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:28 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Egypt-1996b">
<CHAR_METHODS>
<P>RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>190 boys 1 to 24 months with diarrhoea and dehydration (WHO criteria).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:53:14 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (245 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:53:24 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (24 h and total)</P>
<P>Fluid intake</P>
<P>Sodium</P>
<P>Potassium</P>
<P>Weight gain</P>
<P>Children who vomited</P>
<P>Mean weight gain</P>
<P>Duration of diarrhoea</P>
<P>Treatment failures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:32 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:46:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-India-1984a">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:53:34 +0100" MODIFIED_BY="[Empty name]">
<P>65 infants 0 to 3 months old with acute non-cholera diarrhoea and dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:53:52 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (270 mosmol/L)</LI>
<LI>WHO standard ORS (330 mmol/L)</LI>
<LI>IV Ringer's lactate therapy</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:53:59 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (8 h, 24 h)</P>
<P>Weight gain</P>
<P>Fluid intake</P>
<P>Unscheduled IV</P>
<P>Haematologic and electrolyte measures</P>
<P>Urine output</P>
<P>Duration of diarrhoea after hospitalization</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:46:35 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-India-2000a">
<CHAR_METHODS>
<P>RCT<BR/>(double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 11:58:06 +0100" MODIFIED_BY="[Empty name]">
<P>70 children 3 to 24 months with acute non-cholera diarrhoea and some dehydration.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-09 17:47:11 +0000" MODIFIED_BY="[Empty name]">
<P>1. Low osmolarity glucose ORS (224 mosmol/L)</P>
<P>2. WHO standard ORS</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 17:47:15 +0000" MODIFIED_BY="[Empty name]">
<P>Number (%) of patients cured within 10 days</P>
<P>Duration of diarrhoea</P>
<P>Stool output (g/kg/d)</P>
<P>Intake of ORS (ml/kg/d)</P>
<P>Fluid intake (ORS + water + liquid food)</P>
<P>% of weight gain</P>
<P>Mean serum electrolytes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:47:14 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-India-2000b">
<CHAR_METHODS MODIFIED="2008-11-09 17:47:19 +0000" MODIFIED_BY="[Empty name]">
<P>RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-11-09 17:47:24 +0000" MODIFIED_BY="[Empty name]">
<P>170 children</P>
<P>3 months to 5 years old with acute cholera and non-cholera diarrhoea and some to severe dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 11:59:43 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (245 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 11:59:56 +0100" MODIFIED_BY="[Empty name]">
<P>Rehydration frequency (stool/4h)</P>
<P>Rehydration ORS consumed (L)</P>
<P>Rehydration duration (h)</P>
<P>Maintenance frequency (stools/4h)</P>
<P>Maintenance ORS consumed (L)</P>
<P>Maintenance duration (h)</P>
<P>Overall frequency (stool/4h)</P>
<P>Overall ORS consumed (L)</P>
<P>Overall duration (h)</P>
<P>Weight gain (%)</P>
<P>Caloric intake (kcal/kg/d)</P>
<P>Serum sodium (mEq/L)</P>
<P>Urine output (boys) (ml/k/h)</P>
<P>Intravenous fluid (ml/kg)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:47:28 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mexico-1990a">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 12:00:00 +0100" MODIFIED_BY="[Empty name]">
<P>186 children 1 to 36 months old with diarrhoea and dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 12:00:15 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS-90 (240 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 12:00:19 +0100" MODIFIED_BY="[Empty name]">
<P>Need of IV</P>
<P>Sodium</P>
<P>Potassium concentration</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:47:31 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Panama-1982">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 12:00:26 +0100" MODIFIED_BY="[Empty name]">
<P>94 well nourished children 3 months to 2 years old with diarrhoea and dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 12:01:05 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (251 mosmol/L)</LI>
<LI>WHO standard ORS (331 mosmol/L)</LI>
<LI>IV</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-09 17:47:37 +0000" MODIFIED_BY="[Empty name]">
<P>Stool output (8 h and total illness)</P>
<P>Unscheduled IV</P>
<P>Fluid and electrolyte intake</P>
<P>Weight gain</P>
<P>Duration of diarrhoea after discharge</P>
<P>Hyponatraemia</P>
<P>Serum sodium</P>
<P>Stool electrolyte</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:47:39 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-USA-1982">
<CHAR_METHODS>
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 12:01:11 +0100" MODIFIED_BY="[Empty name]">
<P>52 well nourished children 3 months to 2 years old with diarrhoea and dehydration</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 12:01:29 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (251 mosmol/L)</LI>
<LI>WHO standard ORS (331 mosmol/L)</LI>
<LI>IV</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 12:01:17 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output (8 h and total illness)</P>
<P>Unscheduled IV</P>
<P>Fluid and electrolyte intake</P>
<P>Weight gain</P>
<P>Duration of diarrhoea after discharge</P>
<P>Hyponatraemia</P>
<P>Serum sodium</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-09 17:47:42 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-09 17:47:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-WHO-1995">
<CHAR_METHODS MODIFIED="2008-11-09 17:47:47 +0000" MODIFIED_BY="[Empty name]">
<P>Multicentred RCT (double blind)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-22 12:01:35 +0100" MODIFIED_BY="[Empty name]">
<P>447 children aged 1 to 24 months admitted to hospital with diarrhoea and mild to moderate dehydration (WHO classification)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-22 12:01:51 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low osmolarity glucose ORS (224 mosmol/L)</LI>
<LI>WHO standard ORS</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-22 12:01:39 +0100" MODIFIED_BY="[Empty name]">
<P>Stool output at 24 h</P>
<P>Fluid intake</P>
<P>Mean daily consumption of formula milk and semi-solid food.</P>
<P>Weight gain</P>
<P>Serum sodium on admission and at 24 h</P>
<P>Need for unscheduled IV</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-22 12:01:40 +0100" MODIFIED_BY="[Empty name]">
<P>Brazil, Peru, Mexico, India</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>Unscheduled IV: unscheduled intravenous fluid infusion; ORS: oral rehydration solution; RCT: randomized controlled trial; WHO: World Health Organization.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-11-09 17:49:04 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Australia-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared ORS-26 (total 340 mosmol/L, sodium 26 mmol/L, glucose 2.7%) and ORS-60 (total 240 mosmol/L, sodium 60 mmol/L, glucose 1.8%). The ORS-26 was not WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Australia-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared Glucolyte (total 343 mosmol/L, sodium 26 mmol/L, glucose 145 mmol/L) and Gastrolyte (total 240 mosmol/L, sodium 60 mmol/L, glucose 90 mmol/L). The Glucolyte was not WHO standard ORS. This was not an RCT but a open-label study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bangladesh-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared two isotonic sucrose (111 mmol/L) based and glucose (111 mmol/L) based ORS solutions. They did not use reduced osmolarity ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bangladesh-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Maltodextrin containing ORS and WHO standard ORS were compared. They did not clearly report the composition of fluid or exact osmolarities but only mentioned 50 g of maltodextrin was added in the place of glucose which suggests no reduced osmolarity ORS was used.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bangladesh-1996b">
<CHAR_REASON_FOR_EXCLUSION>
<P>In this RCT, they compared WHO standard ORS (311 mosmol/L) and low osmolar ORS (249 mosmol/L). This was excluded because the study was performed in adult patients.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bangladesh-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a RCT comparing WHO standard ORS and low osmolarity ORS. This was excluded because this study was performed in adult patients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Costa-Rica-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared solution A (WHO standard ORS, 311 mosmol/L) and solution B (Pedialyte total 309 osmol/L). They did not use reduced osmolarity ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ecuador-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>This community study was not a RCT but a crossover design in 4 communities. They compared glucose based ORS (310 to 330 mosmol/L) and rice based ORS (220 to 240 mosmol/L).<BR/>None of their outcomes were relevant for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Egypt-1996a">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention group was maltodextrin ORS, and therefore does not meet the inclusion criteria.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>ORS-60 (total 304 mosmol/L, sodium 60 mmol/L, glucose 144 mmol/L) and WHO standard ORS (total 331 mosmol/L) were used. ORS-60 was not a reduced osmolarity ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared two glycin supplemented ORS (total osmolarity 360 mmol/L and 280 mmol/L) and an ORS with sodium 60 mmol/L (total osmolarity 304 mmol/L). They did not use reduced osmolarity ORS or WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Two ORS-60 solutions (sodium 60 mmol/L, each) were compared. One is isotonic (304 mosmol/L and has higher glucose concentration (144 mmol/L), the other hypo-osmolar solution (224 mosmol/L) has 84 mmol/L of glucose. They did not use WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared one standard ORS (sodium 60 mmol/L, total 304 mosmol/L) and the low osmolarity ORS (sodium 60 mmol/L, total 224 mosmol/L). They did not use WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Two hypotonic ORS with osmolarities of 224 osmol/L (sodium 60 mmol/L, glucose 84 mmol/L) and 204 mosmol/L (sodium 60 mmol/L, glucose 64 mmol/L) were compared. They did not use WHO standard ORS and this was not a RCT but an alternate allocation trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-France-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared solution A (total 326 osmol/L, sodium 49 mmol/L glucose 110 mmol/L) and solution D (total 240 osmol/L, sodium 60 mmol/L, glucose 90 mmol/L). They did not use WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guinea_x002d_Bissau-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a community-based RCT where they used WHO standard ORS of 311 osmol/L and reduced osmolarity ORS of 224 osmol/L. None of their outcomes were relevant for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-India-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>In this RCT, they used solution A (sodium 90 mmol/L, potassium 15 mmol/L, chlorine 75 mmol/L, bicarbonate 30 mmol/L, glucose 90 mmol/L) and B (sodium 50 mmol/L, potassium 15 mmol/L, chlorine 50 mmol/L, bicarbonate 15 mmol/L, glucose 170 mmol/L. Both solutions have total osmolarity of 300 mosmol/L.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-India-1984b">
<CHAR_REASON_FOR_EXCLUSION>
<P>In this randomized study, they compared WHO standard ORS (sodium 90 mmol/L, potassium 20 mol/L, bicarbonate 30 mmol/L, chlorine 80 mmol/L, and glucose 111 mmol/L, total 331 mmol/L) and glycin fortified ORS of which osmolarity is not lower because 111 mmol/L of glycine was added.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Iran-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared sucrose high sodium (sodium 90 mmol/L, sucrose 111 mol/L, total 331 osmol/L) and sucrose low sodium (sodium 58 mmol/L, total 278 osmol/L) ORS. They did not use WHO standard ORS.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mexico-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Appears to contain same patients as Mexico 1990a.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mexico-1990b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Appears to contain same patients as Mexico 1990a.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Myanmar-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared WHO standard ORS (311 mmol/L) and maltodextrin/glycine/clycyl-clycine ORS (326 mmol/L). They did not use reduced osmolarity ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Russia-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>They compared WHO standard ORS (331 mmol/L), low ORS (224 mmol/L), and IV fluid infusion, and secondarily lactobacillus GG or placebo. None of their outcomes were relevant for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Turkey-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an RCT but a comparison of data between two separate studies using ORS-60 and ORS-90.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Turkey-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is not an RCT but a comparison between treatment effects of ORS-60 (sodium 60 mmol/L) in malnourished infants with infectious diarrhoea and in a previous study of well-nourished patients. This paper is not an RCT but a comparison of data between two separate studies.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-USA-1972">
<CHAR_REASON_FOR_EXCLUSION>
<P>They used two hypotonic solutions. This is not an RCT. They did not use WHO standard ORS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-USA-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>They used solution A (sodium 50 mmol/L, glucose 111 mEq/L, 389 mosmol/L) and B (sodium 50 mmol/L, glucose 111 mEq/L, 278 mosmol/L). Solution A had 111 mEq/L of glycine additionally. They did not use WHO standard ORS.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>IV: intravenous; ORS: oral rehydration solution; RCT: randomized controlled trial; WHO: World Health Organization.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-10-22 12:02:17 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-10-22 12:02:17 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-09 17:59:15 +0000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Reduced osmolarity ORS compared to WHO standard ORS</NAME>
<DICH_OUTCOME CHI2="5.4724771970306865" CI_END="0.7850982804382517" CI_START="0.4463994113183698" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5920028802418954" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="142" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.10507597385303641" LOG_CI_START="-0.3502763867885605" LOG_EFFECT_SIZE="-0.22767618032079848" METHOD="MH" NO="1" P_CHI2="0.6025057753500336" P_Q="0.0" P_Z="2.7287683259106615E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1004" TOTAL_2="992" WEIGHT="100.0" Z="3.6397745682732676">
<NAME>Need for unscheduled intravenous fluid infusion</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.356532230891699" CI_START="0.16609735070620857" EFFECT_SIZE="0.7466666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.525890821826676" LOG_CI_START="-0.7796372945976753" LOG_EFFECT_SIZE="-0.1268732363854996" ORDER="1" O_E="0.0" SE="0.7668736780560655" STUDY_ID="STD-Bangladesh-1995a" TOTAL_1="19" TOTAL_2="19" VAR="0.588095238095238" WEIGHT="3.093730993687727"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2" O_E="0.0" SE="0.0" STUDY_ID="STD-Bangladesh-1996a" TOTAL_1="18" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0010637766451957" CI_START="0.39529016385974103" EFFECT_SIZE="0.6290553745928339" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="50" LOG_CI_END="4.617467727899962E-4" LOG_CI_START="-0.40308399222061486" LOG_EFFECT_SIZE="-0.20131112272391247" ORDER="3" O_E="0.0" SE="0.23704476466835067" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="0.056190220456673746" WEIGHT="35.64589212085039"/>
<DICH_DATA CI_END="0.946118572608819" CI_START="0.13874020697271017" EFFECT_SIZE="0.3623046875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.024054432094254088" LOG_CI_START="-0.8577976619552781" LOG_EFFECT_SIZE="-0.4409260470247661" ORDER="4" O_E="0.0" SE="0.4897449003159142" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" VAR="0.23985006738544473" WEIGHT="11.465072421559698"/>
<DICH_DATA CI_END="0.965109347203127" CI_START="0.014495825467333233" EFFECT_SIZE="0.11827956989247312" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.015423478162347496" LOG_CI_START="-1.8387570486290725" LOG_EFFECT_SIZE="-0.9270902633957101" ORDER="5" O_E="0.0" SE="1.0710351649388918" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" VAR="1.1471163245356795" WEIGHT="6.137962291476451"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.0087545043744446" CI_START="0.34570896689075736" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.30292686362218996" LOG_CI_START="-0.46128935571743956" LOG_EFFECT_SIZE="-0.07918124604762482" ORDER="7" O_E="0.0" SE="0.44890439017139444" STUDY_ID="STD-India-2000b" TOTAL_1="88" TOTAL_2="82" VAR="0.20151515151515154" WEIGHT="8.519771188263801"/>
<DICH_DATA CI_END="1.3652421541512716" CI_START="0.05539310353848085" EFFECT_SIZE="0.275" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13520968938732866" LOG_CI_START="-1.2565443017268032" LOG_EFFECT_SIZE="-0.5606673061697374" ORDER="8" O_E="0.0" SE="0.8175231836738062" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="0.6683441558441557" WEIGHT="5.287919320937738"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="9" O_E="0.0" SE="0.0" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.02674381898384" CI_START="0.01594836006314561" EFFECT_SIZE="0.41935483870967744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0424472848587059" LOG_CI_START="-1.7972839679135775" LOG_EFFECT_SIZE="-0.3774183415274359" ORDER="10" O_E="0.0" SE="1.6680721947748471" STUDY_ID="STD-USA-1982" TOTAL_1="15" TOTAL_2="20" VAR="2.7824648469809756" WEIGHT="0.9849770569092278"/>
<DICH_DATA CI_END="1.175597490655593" CI_START="0.43410292991205557" EFFECT_SIZE="0.7143740722414647" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="43" LOG_CI_END="0.0702586503883325" LOG_CI_START="-0.36240728294650143" LOG_EFFECT_SIZE="-0.14607431627908443" ORDER="11" O_E="0.0" SE="0.25415011097179285" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" VAR="0.06459227890697461" WEIGHT="28.864674606314967"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="14.308970269885167" CI_END="-0.13958097071440662" CI_START="-0.32680937330105836" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.2331951720077325" ESTIMABLE="YES" I2="30.1137691155448" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="0.1593593927556778" P_Q="1.0" P_Z="1.0484691204058338E-6" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="889" TOTAL_2="887" UNITS="" WEIGHT="100.0" Z="4.882316274553996">
<NAME>Stool output</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.01526606803144015" CI_START="-1.3263573148872578" EFFECT_SIZE="-0.6708116914593489" ESTIMABLE="YES" MEAN_1="4.84" MEAN_2="5.2" ORDER="12" SD_1="0.65" SD_2="0.36" SE="0.3344681987009807" STUDY_ID="STD-Bangladesh-1995a" TOTAL_1="19" TOTAL_2="19" WEIGHT="2.0392836065017823"/>
<CONT_DATA CI_END="0.25390122643262664" CI_START="-0.7625901974861056" EFFECT_SIZE="-0.25434448552673944" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="4.63" ORDER="13" SD_1="0.61" SD_2="0.37" SE="0.25931380166592005" STUDY_ID="STD-Bangladesh-1995b" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.3926263134356396"/>
<CONT_DATA CI_END="0.08028935823117744" CI_START="-1.1248082762853648" EFFECT_SIZE="-0.5222594590270937" ESTIMABLE="YES" MEAN_1="4.26" MEAN_2="4.57" ORDER="14" SD_1="0.52" SD_2="0.62" SE="0.3074285150192041" STUDY_ID="STD-Bangladesh-1996a" TOTAL_1="18" TOTAL_2="28" WEIGHT="2.4137872890094623"/>
<CONT_DATA CI_END="0.07044611562276037" CI_START="-0.2314492141957863" EFFECT_SIZE="-0.08050154928651296" ESTIMABLE="YES" MEAN_1="4.56" MEAN_2="4.61" ORDER="15" SD_1="0.59" SD_2="0.65" SE="0.07701552992806462" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" WEIGHT="38.46189469194508"/>
<CONT_DATA CI_END="0.09118932545328312" CI_START="-0.5739448240888616" EFFECT_SIZE="-0.24137774931778927" ESTIMABLE="YES" MEAN_1="1.42" MEAN_2="1.6" ORDER="16" SD_1="0.78" SD_2="0.7" SE="0.16968019687826869" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" WEIGHT="7.923644305704393"/>
<CONT_DATA CI_END="-0.42483218187151284" CI_START="-1.7454835480282074" EFFECT_SIZE="-1.08515786494986" ESTIMABLE="YES" MEAN_1="5.06" MEAN_2="5.47" ORDER="17" SD_1="0.31" SD_2="0.42" SE="0.336907049459537" STUDY_ID="STD-Egypt-1994" TOTAL_1="20" TOTAL_2="21" WEIGHT="2.0098659560963004"/>
<CONT_DATA CI_END="0.05417832204782452" CI_START="-0.5165528847420053" EFFECT_SIZE="-0.23118728134709043" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.71" ORDER="18" SD_1="1.39" SD_2="1.28" SE="0.14559737099550932" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" WEIGHT="10.761683721639193"/>
<CONT_DATA CI_END="0.4349502731010731" CI_START="-0.7489506701892128" EFFECT_SIZE="-0.15700019854406982" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="4.3" ORDER="19" SD_1="0.65" SD_2="0.6" SE="0.3020210964662477" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" WEIGHT="2.5009944658825707"/>
<CONT_DATA CI_END="0.3069723879543441" CI_START="-0.6842158509903856" EFFECT_SIZE="-0.18862173151802075" ESTIMABLE="YES" MEAN_1="1.08" MEAN_2="1.23" ORDER="20" SD_1="0.87" SD_2="0.68" SE="0.2528587889275252" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="30" WEIGHT="3.5680520690318978"/>
<CONT_DATA CI_END="0.302845201900016" CI_START="-0.9455891286513856" EFFECT_SIZE="-0.3213719633756848" ESTIMABLE="YES" MEAN_1="1.12" MEAN_2="1.35" ORDER="21" SD_1="0.79" SD_2="0.6" SE="0.31848399776702335" STUDY_ID="STD-USA-1982" TOTAL_1="20" TOTAL_2="20" WEIGHT="2.2491170527019615"/>
<CONT_DATA CI_END="-0.15037707991019064" CI_START="-0.52726091312454" EFFECT_SIZE="-0.33881899651736536" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="4.45" ORDER="22" SD_1="0.82" SD_2="0.83" SE="0.09614560170165395" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" WEIGHT="24.679050528051718"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="6.42732124056432" CI_END="0.9235510380882165" CI_START="0.5520016702778868" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7140040025178933" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="275" I2="22.207093548649212" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.034539099197641566" LOG_CI_START="-0.2580596081559967" LOG_EFFECT_SIZE="-0.14629935367681912" METHOD="PETO" NO="3" P_CHI2="0.26682980118053856" P_Q="1.0" P_Z="0.010297267707738623" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="648" WEIGHT="100.0" Z="2.5656837084374824">
<NAME>Episode of vomiting during rehydration</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.158757720258789" CI_START="0.2567806843410177" EFFECT_SIZE="0.7445315874659093" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.3342039037242335" LOG_CI_START="-0.590437648047152" LOG_EFFECT_SIZE="-0.1281168721614593" ORDER="23" O_E="-1.0" SE="0.5431390245600108" STUDY_ID="STD-Bangladesh-1995b" TOTAL_1="30" TOTAL_2="30" VAR="3.389830508474576" WEIGHT="5.8437004180439835"/>
<DICH_DATA CI_END="1.1560718502185012" CI_START="0.6246860980120538" EFFECT_SIZE="0.8498129283169156" ESTIMABLE="YES" EVENTS_1="198" EVENTS_2="207" LOG_CI_END="0.06298482645797453" LOG_CI_START="-0.20433815889123297" LOG_EFFECT_SIZE="-0.07067666621662919" ORDER="24" O_E="-6.599999999999994" SE="0.15702684486424337" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="40.55572700296736" WEIGHT="69.91367805818882"/>
<DICH_DATA CI_END="0.81333168378029" CI_START="0.22042879840050045" EFFECT_SIZE="0.42341672824387216" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="32" LOG_CI_END="-0.08973230919139712" LOG_CI_START="-0.6567316667649524" LOG_EFFECT_SIZE="-0.3732319879781748" ORDER="25" O_E="-7.747368421052631" SE="0.33305822933079215" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" VAR="9.014874027173196" WEIGHT="15.540665820755729"/>
<DICH_DATA CI_END="1.8240741047282762" CI_START="0.07476910525319096" EFFECT_SIZE="0.3693025707005687" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2610424779731137" LOG_CI_START="-1.126277816436735" LOG_EFFECT_SIZE="-0.4326176692318107" ORDER="26" O_E="-1.5" SE="0.8149188082825577" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" VAR="1.505813953488372" WEIGHT="2.595860060701457"/>
<DICH_DATA CI_END="2.092713827674564" CI_START="0.20116600854997488" EFFECT_SIZE="0.6488319410684341" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3207098439339609" LOG_CI_START="-0.6964454010828903" LOG_EFFECT_SIZE="-0.1878677785744647" ORDER="27" O_E="-1.211764705882353" SE="0.5974820259225647" STUDY_ID="STD-India-2000b" TOTAL_1="88" TOTAL_2="82" VAR="2.8012399418521325" WEIGHT="4.82903407067663"/>
<DICH_DATA CI_END="1.318824348801242" CI_START="0.013875686833236662" EFFECT_SIZE="0.13527599067097354" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.12018695670921326" LOG_CI_START="-1.8577455105114435" LOG_EFFECT_SIZE="-0.868779276901115" ORDER="28" O_E="-1.4819277108433735" SE="1.1618473221690324" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="0.7408015413241136" WEIGHT="1.2770615716333884"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6286453251302002" CI_END="2.243408571593679" CI_START="0.9280526627699497" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.4429141688085412" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.35090837488917126" LOG_CI_START="-0.032427378844217994" LOG_EFFECT_SIZE="0.1592404980224766" METHOD="PETO" NO="4" P_CHI2="0.4429394542012992" P_Q="1.0" P_Z="0.10344709570169974" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="562" TOTAL_2="558" WEIGHT="100.00000000000001" Z="1.628366975762694">
<NAME>Presence of hyponatremia after rehydration</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.123370693388497" CI_START="0.7693083654458179" EFFECT_SIZE="1.2780950032631602" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="29" LOG_CI_END="0.32702581896092864" LOG_CI_START="-0.11389954502591519" LOG_EFFECT_SIZE="0.10656313696750669" ORDER="29" O_E="3.657777777777781" SE="0.25900174142162463" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="14.9071503535187" WEIGHT="75.58375979435088"/>
<DICH_DATA CI_END="7.045984628056077" CI_START="0.133871729356177" EFFECT_SIZE="0.9712147791168061" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479416913632901" LOG_CI_START="-0.8733111263555371" LOG_EFFECT_SIZE="-0.012684717496123547" ORDER="30" O_E="-0.02857142857142847" SE="1.011072425466901" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" VAR="0.9782175891939509" WEIGHT="4.959858962634822"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="31" O_E="0.0" SE="0.0" STUDY_ID="STD-Egypt-1994" TOTAL_1="20" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.954029043256161" CI_START="0.9401116534988058" EFFECT_SIZE="2.5568660000739714" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.842236500166559" LOG_CI_START="-0.02682056382712458" LOG_EFFECT_SIZE="0.4077079681697173" ORDER="32" O_E="3.6024096385542173" SE="0.5104884212917368" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="3.8373216854273613" WEIGHT="19.456381243014306"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="33" O_E="0.0" SE="0.0" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="34" O_E="0.0" SE="0.0" STUDY_ID="STD-USA-1982" TOTAL_1="15" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.426171528532632" CI_END="0.8164333786954479" CI_START="0.4583096771686827" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6117019848093086" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="134" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.0880792480925247" LOG_CI_START="-0.33884097256846063" LOG_EFFECT_SIZE="-0.21346011033049267" METHOD="MH" NO="5" P_CHI2="0.4898220349928021" P_Q="0.0" P_Z="8.474096462461124E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="852" TOTAL_2="836" WEIGHT="99.99999999999999" Z="3.336826058746145">
<NAME>Need for unscheduled intravenous fluid infusion (sensitivity analysis)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.356532230891699" CI_START="0.16609735070620857" EFFECT_SIZE="0.7466666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.525890821826676" LOG_CI_START="-0.7796372945976753" LOG_EFFECT_SIZE="-0.1268732363854996" ORDER="35" O_E="0.0" SE="0.7668736780560655" STUDY_ID="STD-Bangladesh-1995a" TOTAL_1="19" TOTAL_2="19" VAR="0.588095238095238" WEIGHT="3.3007858710321893"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="36" O_E="0.0" SE="0.0" STUDY_ID="STD-Bangladesh-1996a" TOTAL_1="18" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0010637766451957" CI_START="0.39529016385974103" EFFECT_SIZE="0.6290553745928339" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="50" LOG_CI_END="4.617467727899962E-4" LOG_CI_START="-0.40308399222061486" LOG_EFFECT_SIZE="-0.20131112272391247" ORDER="37" O_E="0.0" SE="0.23704476466835067" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="0.056190220456673746" WEIGHT="38.03157330514718"/>
<DICH_DATA CI_END="0.946118572608819" CI_START="0.13874020697271017" EFFECT_SIZE="0.3623046875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.024054432094254088" LOG_CI_START="-0.8577976619552781" LOG_EFFECT_SIZE="-0.4409260470247661" ORDER="38" O_E="0.0" SE="0.4897449003159142" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" VAR="0.23985006738544473" WEIGHT="12.232398077486147"/>
<DICH_DATA CI_END="0.965109347203127" CI_START="0.014495825467333233" EFFECT_SIZE="0.11827956989247312" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.015423478162347496" LOG_CI_START="-1.8387570486290725" LOG_EFFECT_SIZE="-0.9270902633957101" ORDER="39" O_E="0.0" SE="1.0710351649388918" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" VAR="1.1471163245356795" WEIGHT="6.548759168127864"/>
<DICH_DATA CI_END="2.0087545043744446" CI_START="0.34570896689075736" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.30292686362218996" LOG_CI_START="-0.46128935571743956" LOG_EFFECT_SIZE="-0.07918124604762482" ORDER="40" O_E="0.0" SE="0.44890439017139444" STUDY_ID="STD-India-2000b" TOTAL_1="88" TOTAL_2="82" VAR="0.20151515151515154" WEIGHT="9.089975961073117"/>
<DICH_DATA CI_END="1.175597490655593" CI_START="0.43410292991205557" EFFECT_SIZE="0.7143740722414647" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="43" LOG_CI_END="0.0702586503883325" LOG_CI_START="-0.36240728294650143" LOG_EFFECT_SIZE="-0.14607431627908443" ORDER="41" O_E="0.0" SE="0.25415011097179285" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" VAR="0.06459227890697461" WEIGHT="30.796507617133496"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.729888069251061" CI_END="-0.10519595785699137" CI_START="-0.3051999517470199" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.20519795480200564" ESTIMABLE="YES" I2="12.738260511020115" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="0.33339555460918513" P_Q="1.0" P_Z="5.777331336395885E-5" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="775" TOTAL_2="775" UNITS="" WEIGHT="100.0" Z="4.021725699481246">
<NAME>Stool output (sensitivity analysis)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.25390122643262664" CI_START="-0.7625901974861056" EFFECT_SIZE="-0.25434448552673944" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="4.63" ORDER="42" SD_1="0.61" SD_2="0.37" SE="0.25931380166592005" STUDY_ID="STD-Bangladesh-1995b" TOTAL_1="30" TOTAL_2="30" WEIGHT="3.871416517504558"/>
<CONT_DATA CI_END="0.08028935823117744" CI_START="-1.1248082762853648" EFFECT_SIZE="-0.5222594590270937" ESTIMABLE="YES" MEAN_1="4.26" MEAN_2="4.57" ORDER="43" SD_1="0.52" SD_2="0.62" SE="0.3074285150192041" STUDY_ID="STD-Bangladesh-1996a" TOTAL_1="18" TOTAL_2="28" WEIGHT="2.7544371578461666"/>
<CONT_DATA CI_END="0.07044611562276037" CI_START="-0.2314492141957863" EFFECT_SIZE="-0.08050154928651296" ESTIMABLE="YES" MEAN_1="4.56" MEAN_2="4.61" ORDER="44" SD_1="0.59" SD_2="0.65" SE="0.07701552992806462" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" WEIGHT="43.889895511105436"/>
<CONT_DATA CI_END="0.09118932545328312" CI_START="-0.5739448240888616" EFFECT_SIZE="-0.24137774931778927" ESTIMABLE="YES" MEAN_1="1.42" MEAN_2="1.6" ORDER="45" SD_1="0.78" SD_2="0.7" SE="0.16968019687826869" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" WEIGHT="9.04188219093021"/>
<CONT_DATA CI_END="0.05417832204782452" CI_START="-0.5165528847420053" EFFECT_SIZE="-0.23118728134709043" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.71" ORDER="46" SD_1="1.39" SD_2="1.28" SE="0.14559737099550932" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" WEIGHT="12.280444784360204"/>
<CONT_DATA CI_END="-0.15037707991019064" CI_START="-0.52726091312454" EFFECT_SIZE="-0.33881899651736536" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="4.45" ORDER="47" SD_1="0.82" SD_2="0.83" SE="0.09614560170165395" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" WEIGHT="28.16192383825343"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Reduced osmolarity ORS (stratified by sodium concentration) compared to WHO standard ORS</NAME>
<DICH_OUTCOME CHI2="5.4001812183266775" CI_END="0.7825939947271785" CI_START="0.44038875851533277" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5870652414846727" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="137" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.10646348900223773" LOG_CI_START="-0.3561637754792821" LOG_EFFECT_SIZE="-0.23131363224075993" METHOD="MH" NO="1" P_CHI2="0.4936024776518977" P_Q="0.0" P_Z="2.820141033302183E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="967" TOTAL_2="958" WEIGHT="100.00000000000001" Z="3.631284486865912">
<NAME>Need for unscheduled intravenous fluid infusion</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0997094732014488" CI_END="1.1523486125482751" CI_START="0.43087324280989386" DF="1.0" EFFECT_SIZE="0.7046390448564125" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="44" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.06158388325613601" LOG_CI_START="-0.3656504747230105" LOG_EFFECT_SIZE="-0.1520332957334372" NO="1" P_CHI2="0.7521785817621705" P_Z="0.16303868227285823" STUDIES="4" TAU2="0.0" TOTAL_1="291" TOTAL_2="293" WEIGHT="30.802601286073507" Z="1.394924254209951">
<NAME>60 to 74 mmol</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="48" O_E="0.0" SE="0.0" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="49" O_E="0.0" SE="0.0" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="33" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.02674381898384" CI_START="0.01594836006314561" EFFECT_SIZE="0.41935483870967744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0424472848587059" LOG_CI_START="-1.7972839679135775" LOG_EFFECT_SIZE="-0.3774183415274359" ORDER="50" O_E="0.0" SE="1.6680721947748471" STUDY_ID="STD-USA-1982" TOTAL_1="15" TOTAL_2="20" VAR="2.7824648469809756" WEIGHT="1.0164224327376266"/>
<DICH_DATA CI_END="1.175597490655593" CI_START="0.43410292991205557" EFFECT_SIZE="0.7143740722414647" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="43" LOG_CI_END="0.0702586503883325" LOG_CI_START="-0.36240728294650143" LOG_EFFECT_SIZE="-0.14607431627908443" ORDER="51" O_E="0.0" SE="0.25415011097179285" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" VAR="0.06459227890697461" WEIGHT="29.78617885333588"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.7242645659707225" CI_END="0.7628153739929534" CI_START="0.3748408637678451" DF="4.0" EFFECT_SIZE="0.5347283176370131" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="93" I2="15.3307367920853" ID="CMP-002.01.02" LOG_CI_END="-0.11758056264619376" LOG_CI_START="-0.4261530700214565" LOG_EFFECT_SIZE="-0.2718668163338252" NO="2" P_CHI2="0.3167773170320768" P_Z="5.530752593425321E-4" STUDIES="5" TAU2="0.0" TOTAL_1="676" TOTAL_2="665" WEIGHT="69.1973987139265" Z="3.453639944389808">
<NAME>75 mmol to 84 mmol</NAME>
<DICH_DATA CI_END="1.0010637766451957" CI_START="0.39529016385974103" EFFECT_SIZE="0.6290553745928339" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="50" LOG_CI_END="4.617467727899962E-4" LOG_CI_START="-0.40308399222061486" LOG_EFFECT_SIZE="-0.20131112272391247" ORDER="52" O_E="0.0" SE="0.23704476466835067" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="0.056190220456673746" WEIGHT="36.783886621956825"/>
<DICH_DATA CI_END="0.946118572608819" CI_START="0.13874020697271017" EFFECT_SIZE="0.3623046875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.024054432094254088" LOG_CI_START="-0.8577976619552781" LOG_EFFECT_SIZE="-0.4409260470247661" ORDER="53" O_E="0.0" SE="0.4897449003159142" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" VAR="0.23985006738544473" WEIGHT="11.831094664074712"/>
<DICH_DATA CI_END="0.965109347203127" CI_START="0.014495825467333233" EFFECT_SIZE="0.11827956989247312" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.015423478162347496" LOG_CI_START="-1.8387570486290725" LOG_EFFECT_SIZE="-0.9270902633957101" ORDER="54" O_E="0.0" SE="1.0710351649388918" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" VAR="1.1471163245356795" WEIGHT="6.333916633480788"/>
<DICH_DATA CI_END="2.0087545043744446" CI_START="0.34570896689075736" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.30292686362218996" LOG_CI_START="-0.46128935571743956" LOG_EFFECT_SIZE="-0.07918124604762482" ORDER="55" O_E="0.0" SE="0.44890439017139444" STUDY_ID="STD-India-2000b" TOTAL_1="88" TOTAL_2="82" VAR="0.20151515151515154" WEIGHT="8.791764738882726"/>
<DICH_DATA CI_END="1.3652421541512716" CI_START="0.05539310353848085" EFFECT_SIZE="0.275" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.13520968938732866" LOG_CI_START="-1.2565443017268032" LOG_EFFECT_SIZE="-0.5606673061697374" ORDER="56" O_E="0.0" SE="0.8175231836738062" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="0.6683441558441557" WEIGHT="5.456736055531447"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.761847564582153" CI_END="-0.09815661642528274" CI_START="-0.2953597307039004" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.19675817356459158" ESTIMABLE="YES" I2="0.0" I2_Q="66.01993219865092" ID="CMP-002.02" NO="2" P_CHI2="0.5747008087245402" P_Q="0.08625581384675352" P_Z="9.188295591354712E-5" Q="2.942901720638409" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="789" UNITS="" WEIGHT="100.0" Z="3.911083607996494">
<NAME>Stool output</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.49236838955605633" CI_END="-0.14736124610619386" CI_START="-0.4733214031575742" DF="3.0" EFFECT_SIZE="-0.310341324631884" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.9205648634470268" P_Z="1.8989069452793523E-4" STUDIES="4" TAU2="0.0" TOTAL_1="296" TOTAL_2="290" WEIGHT="36.60146776690631" Z="3.732099190865635">
<NAME>60 to 74 mmol</NAME>
<CONT_DATA CI_END="0.4349502731010731" CI_START="-0.7489506701892128" EFFECT_SIZE="-0.15700019854406982" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="4.3" ORDER="57" SD_1="0.65" SD_2="0.6" SE="0.3020210964662477" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" WEIGHT="2.774577148550164"/>
<CONT_DATA CI_END="0.28215475802713275" CI_START="-0.7096973494679798" EFFECT_SIZE="-0.21377129572042355" ESTIMABLE="YES" MEAN_1="1.06" MEAN_2="1.23" ORDER="58" SD_1="0.87" SD_2="0.68" SE="0.2530281462615424" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="30" WEIGHT="3.953062650678999"/>
<CONT_DATA CI_END="0.302845201900016" CI_START="-0.9455891286513856" EFFECT_SIZE="-0.3213719633756848" ESTIMABLE="YES" MEAN_1="1.12" MEAN_2="1.35" ORDER="59" SD_1="0.79" SD_2="0.6" SE="0.31848399776702335" STUDY_ID="STD-USA-1982" TOTAL_1="20" TOTAL_2="20" WEIGHT="2.495146976120642"/>
<CONT_DATA CI_END="-0.15037707991019064" CI_START="-0.52726091312454" EFFECT_SIZE="-0.33881899651736536" ESTIMABLE="YES" MEAN_1="4.17" MEAN_2="4.45" ORDER="60" SD_1="0.82" SD_2="0.83" SE="0.09614560170165395" STUDY_ID="STD-WHO-1995" TOTAL_1="221" TOTAL_2="218" WEIGHT="27.378680991556504"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.3265774543876878" CI_END="-0.007348724218309566" CI_START="-0.2550191594931966" DF="2.0" EFFECT_SIZE="-0.13118394185575308" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" NO="2" P_CHI2="0.5151543812193216" P_Z="0.03786864737604583" STUDIES="3" TAU2="0.0" TOTAL_1="506" TOTAL_2="499" WEIGHT="63.39853223309368" Z="2.0762736666724253">
<NAME>75 to 84 mmol</NAME>
<CONT_DATA CI_END="0.07044611562276037" CI_START="-0.2314492141957863" EFFECT_SIZE="-0.08050154928651296" ESTIMABLE="YES" MEAN_1="4.56" MEAN_2="4.61" ORDER="61" SD_1="0.59" SD_2="0.65" SE="0.07701552992806462" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" WEIGHT="42.66922440572257"/>
<CONT_DATA CI_END="0.09118932545328312" CI_START="-0.5739448240888616" EFFECT_SIZE="-0.24137774931778927" ESTIMABLE="YES" MEAN_1="1.42" MEAN_2="1.6" ORDER="62" SD_1="0.78" SD_2="0.7" SE="0.16968019687826869" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" WEIGHT="8.790408265093413"/>
<CONT_DATA CI_END="0.05417832204782452" CI_START="-0.5165528847420053" EFFECT_SIZE="-0.23118728134709043" ESTIMABLE="YES" MEAN_1="2.4" MEAN_2="2.71" ORDER="63" SD_1="1.39" SD_2="1.28" SE="0.14559737099550932" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" WEIGHT="11.938899562277705"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.278283321774749" CI_END="0.9090814709567633" CI_START="0.5420028206386868" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7019435315243898" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="275" I2="5.27223161035585" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.04139719400416727" LOG_CI_START="-0.2659984533423702" LOG_EFFECT_SIZE="-0.15369782367326876" METHOD="MH" NO="3" P_CHI2="0.3828704723334818" P_Q="0.0" P_Z="0.007308240106411751" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="657" TOTAL_2="648" WEIGHT="100.0" Z="2.6824622425485707">
<NAME>Episodes of vomiting</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.545535612719855" CI_END="1.467474915024175" CI_START="0.23856721746326412" DF="1.0" EFFECT_SIZE="0.5916852264291017" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="26" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.16657068616517706" LOG_CI_START="-0.6223892348189235" LOG_EFFECT_SIZE="-0.22790927432687325" NO="1" P_CHI2="0.46014769071136674" P_Z="0.2574824498727263" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="52" WEIGHT="8.891218643246741" Z="1.1323616258381082">
<NAME>60 to 74 mmol</NAME>
<DICH_DATA CI_END="2.174541039220514" CI_START="0.2520000649175371" EFFECT_SIZE="0.7402597402597403" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="21" LOG_CI_END="0.3373676083402031" LOG_CI_START="-0.598599347340184" LOG_EFFECT_SIZE="-0.13061586949999046" ORDER="64" O_E="0.0" SE="0.5497916228778118" STUDY_ID="STD-Bangladesh-1995b" TOTAL_1="30" TOTAL_2="30" VAR="0.302270828586618" WEIGHT="5.59084052771343"/>
<DICH_DATA CI_END="1.9815441946123036" CI_START="0.058338340529728944" EFFECT_SIZE="0.34" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2970037628989314" LOG_CI_START="-1.234045928814421" LOG_EFFECT_SIZE="-0.46852108295774486" ORDER="65" O_E="0.0" SE="0.8993461677306268" STUDY_ID="STD-India-1984a" TOTAL_1="22" TOTAL_2="22" VAR="0.8088235294117647" WEIGHT="3.300378115533312"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.587644039879468" CI_END="0.9334410773074222" CI_START="0.5441653892122043" DF="3.0" EFFECT_SIZE="0.712703533834127" ESTIMABLE="YES" EVENTS_1="217" EVENTS_2="249" I2="34.606957865047875" ID="CMP-002.03.02" LOG_CI_END="-0.029913091328074674" LOG_CI_START="-0.2642690842985695" LOG_EFFECT_SIZE="-0.14709108781332209" NO="2" P_CHI2="0.20460466408909483" P_Z="0.01388202283143172" STUDIES="4" TAU2="0.0" TOTAL_1="605" TOTAL_2="596" WEIGHT="91.10878135675325" Z="2.4603017905091553">
<NAME>75 to 84 mmol</NAME>
<DICH_DATA CI_END="1.1285162487401204" CI_START="0.6094457778581992" EFFECT_SIZE="0.8293186739963352" ESTIMABLE="YES" EVENTS_1="196" EVENTS_2="207" LOG_CI_END="0.0525078165705104" LOG_CI_START="-0.21506492732942986" LOG_EFFECT_SIZE="-0.08127855537945972" ORDER="66" O_E="0.0" SE="0.15717355427326854" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="0.024703526162892092" WEIGHT="64.57299795644776"/>
<DICH_DATA CI_END="0.8139644328900969" CI_START="0.20677847256650533" EFFECT_SIZE="0.41025641025641024" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="32" LOG_CI_END="-0.08939457169193107" LOG_CI_START="-0.6844946770492178" LOG_EFFECT_SIZE="-0.3869446243705744" ORDER="67" O_E="0.0" SE="0.3495647476799009" STUDY_ID="STD-Egypt-1996b" TOTAL_1="94" TOTAL_2="96" VAR="0.12219551282051282" WEIGHT="19.07688032422792"/>
<DICH_DATA CI_END="2.120249534175053" CI_START="0.19648223707576895" EFFECT_SIZE="0.6454388984509466" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.32638697646547793" LOG_CI_START="-0.7066767057907017" LOG_EFFECT_SIZE="-0.1901448646626119" ORDER="68" O_E="0.0" SE="0.6068267207049806" STUDY_ID="STD-India-2000b" TOTAL_1="88" TOTAL_2="82" VAR="0.36823866896156054" WEIGHT="4.962992126205505"/>
<DICH_DATA CI_END="2.7755527480180215" CI_START="0.007175658388117031" EFFECT_SIZE="0.14112554112554113" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44334948529982954" LOG_CI_START="-2.1441382449482402" LOG_EFFECT_SIZE="-0.8503943798242053" ORDER="69" O_E="0.0" SE="1.51990310101855" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="2.3101054364858045" WEIGHT="2.495910949872067"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.642206995428244" CI_END="2.2640734423742632" CI_START="0.9256188349819799" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4476425739954273" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.35489051045817605" LOG_CI_START="-0.03356781671240527" LOG_EFFECT_SIZE="0.16066134687288539" METHOD="MH" NO="4" P_CHI2="0.4399461311760171" P_Q="0.0" P_Z="0.10496798256817283" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="562" TOTAL_2="609" WEIGHT="99.99999999999999" Z="1.6212315790582925">
<NAME>Presence of hyponatraemia</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="122" WEIGHT="0.0" Z="0.0">
<NAME>60 to 74 mmol</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="70" O_E="0.0" SE="0.0" STUDY_ID="STD-Egypt-1994" TOTAL_1="20" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="71" O_E="0.0" SE="0.0" STUDY_ID="STD-Panama-1982" TOTAL_1="33" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="72" O_E="0.0" SE="0.0" STUDY_ID="STD-USA-1982" TOTAL_1="15" TOTAL_2="71" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.642206995428244" CI_END="2.2640734423742632" CI_START="0.9256188349819799" DF="2.0" EFFECT_SIZE="1.4476425739954273" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="36" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.35489051045817605" LOG_CI_START="-0.03356781671240527" LOG_EFFECT_SIZE="0.16066134687288539" NO="2" P_CHI2="0.4399461311760171" P_Z="0.10496798256817283" STUDIES="3" TAU2="0.0" TOTAL_1="494" TOTAL_2="487" WEIGHT="99.99999999999999" Z="1.6212315790582925">
<NAME>75 to 84 mmol</NAME>
<DICH_DATA CI_END="2.134633744069805" CI_START="0.767602876238711" EFFECT_SIZE="1.2800589836660616" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="29" LOG_CI_END="0.329323370426847" LOG_CI_START="-0.114863406614705" LOG_EFFECT_SIZE="0.10722998190607098" ORDER="73" O_E="0.0" SE="0.2609175115942151" STUDY_ID="STD-CHOICE-2001" TOTAL_1="341" TOTAL_2="334" VAR="0.06807794785651737" WEIGHT="80.84698652925356"/>
<DICH_DATA CI_END="7.093439698588821" CI_START="0.13292128857106544" EFFECT_SIZE="0.9710144927536232" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.850856881144493" LOG_CI_START="-0.8764054572173507" LOG_EFFECT_SIZE="-0.01277428803642889" ORDER="74" O_E="0.0" SE="1.0146024476402158" STUDY_ID="STD-Colombia-2000" TOTAL_1="71" TOTAL_2="69" VAR="1.0294181267575169" WEIGHT="6.101647001555588"/>
<DICH_DATA CI_END="8.070141641111192" CI_START="0.9090744016561416" EFFECT_SIZE="2.7085714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.9068811572020177" LOG_CI_START="-0.04140057122643645" LOG_EFFECT_SIZE="0.4327402929877906" ORDER="75" O_E="0.0" SE="0.5570253813491347" STUDY_ID="STD-Mexico-1990a" TOTAL_1="82" TOTAL_2="84" VAR="0.3102772754671489" WEIGHT="13.051366469190842"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-09 17:58:21 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-09 17:58:21 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-09 17:58:08 +0000" MODIFIED_BY="[Empty name]">Stool output</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 17:58:21 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="6" ROWS="14">
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Trials</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcome</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Value</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="BOTTOM">
<P>ORS</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Differences</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Low osmolarity</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>WHO standard</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-WHO-1995" TYPE="STUDY">WHO 1995</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 24 h (g/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Geometric mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 221; mean = 65; 95% confidence interval 58 to 73</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 218; mean = 86; 95% confidence interval 77 to 96<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Ratio standard/reduced = 1.32 95% confidence interval 1.12 to 1.54</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-India-2000a" TYPE="STUDY">India 2000a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output during observation period (g/kg/d)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 33; mean = 61.0; standard deviation = 24.5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 37; mean = 75.0; standard deviation = 29.4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Egypt-1996b" TYPE="STUDY">Egypt 1996b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output for rehydration phase (g/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Geometric mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 94; mean = 11; 95% confidence interval 8 to 14</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 96; mean = 15; 95% confidence interval 12 to 20</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bangladesh-1995a" TYPE="STUDY">Bangladesh 1995a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 0 to 24 h (ml/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 19; mean = 156; standard deviation = 113.4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 19; mean = 193; standard deviation = 71.2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Colombia-2000" TYPE="STUDY">Colombia 2000</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output for rehydration period (g/kg/h)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 71; mean = 5.6; standard deviation = 5.1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 69; mean = 6.3; standard deviation = 5.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Egypt-1994" TYPE="STUDY">Egypt 1994</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 24 h (g/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 20; mean = 165; standard deviation = 52</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 21; mean = 260; standard deviation 114</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bangladesh-1995b" TYPE="STUDY">Bangladesh 1995b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 0 to24 h (ml/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 30; mean = 109; standard deviation = 73.8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 30; mean = 110; standard deviation = 42.7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bangladesh-1996a" TYPE="STUDY">Bangladesh 1996a</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 0 to 24 h (g/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 18; mean = 80.9; standard deviation = 45.3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 28; mean = 117.8; standard deviation = 81.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-India-1984a" TYPE="STUDY">India 1984a</LINK>; <LINK REF="STD-India-1984b" TYPE="STUDY">India 1984b</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 24 h (ml/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 22; mean = 82.3; standard deviation = 60</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 22; mean = 88.1; standard deviation = 58.2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Panama-1982" TYPE="STUDY">Panama 1982</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output during first 8 h (ml/kg/h)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 33; mean = 4.3; standard deviation = 4.6</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 30; mean = 4.3; standard deviation = 3.3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-USA-1982" TYPE="STUDY">USA 1982</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output during the first 8 h (ml/kg/h)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 15; mean = 4.2; standard deviation = 3.9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 20; mean = 4.6; standard deviation = 4.0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-CHOICE-2001" TYPE="STUDY">CHOICE 2001</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stool output at 24 h (g/kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Arithmetic mean</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 341; mean = 114; standard deviation = 73.9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>n = 334; mean = 125; standard deviation = 91.4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8212;</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>